Dopamine D1-like and D2-like receptors in the dorsal striatum control different aspects of attentional performance in the five-choice serial reaction time task under a condition of increased activity of corticostriatal inputs

Neuropsychopharmacology

Volumn 38, Issue 5, 2013, Pages 701-714

  Agnoli, Laura ^a   Mainolfi, Pierangela ^a   Invernizzi, Roberto W ^a   Carli, Mirjana ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

attention; behavioral flexibility; DA and GABA release; dorsal striatum; GLU; prefrontal cortex

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 4 AMINOBUTYRIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMIC ACID; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; QUINPIROLE; 3-(2-CARBOXYPIPERAZIN-4-YL)PROPYL-1-PHOSPHONIC ACID; AMINO ACID; AMINO ACID RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; PIPERAZINE DERIVATIVE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ARTICLE; ATTENTION; CONTROLLED STUDY; CORPUS STRIATUM; DORSOMEDIAL STRIATUM; DRUG EFFECT; FIVE CHOICE SERIAL REACTION TIME; HISTOPATHOLOGY; LATENT PERIOD; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRESERVATION; PRIORITY JOURNAL; RAT; REACTION TIME; TASK PERFORMANCE; VISUAL DISCRIMINATION; ANALYSIS OF VARIANCE; ANIMAL; ATTENTION DEFICIT DISORDER; CHEMICALLY INDUCED DISORDER; DECISION MAKING; DOSE RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; PHYSIOLOGY;

AMINO ACIDS; ANALYSIS OF VARIANCE; ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHOICE BEHAVIOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICRODIALYSIS; PIPERAZINES; PREFRONTAL CORTEX; RATS; REACTION TIME; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 84875229995     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.236     Document Type: Article

References (98)

1. Agnoli L, Carli M (2011). Synergistic interaction of dopamine D(1) and glutamate N-methyl-d-aspartate receptors in the rat dorsal striatum controls attention. Neuroscience 185: 39-49.
2. Amalric M, Ouagazzal A, Baunez C, Nieoullon A (1994). Functional interactions between glutamate and dopamine in the rat striatum. Neurochem Int 25: 123-131.
3. Anden NE, Hfuxe K, Hamberger B, Hokfelt T (1966). A quantitative study on the nigro-neostriatal dopamine neuron system in the rat. Acta Physiol Scand 67: 306-312.
4. Arnsten AF (1997). Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 11: 151-162.
5. Bailey KR, Mair RG (2006). The role of striatum in initiation and execution of learned action sequences in rats. J Neurosci 26: 1016-1025.
6. Balla A, Nattini ME, Sershen H, Lajtha A, Dunlop DS, Javitt DC (2009). GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum. Neuropharmacology 56: 915-921.
7. Balleine BW, O'Doherty JP (2010). Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 35: 48-69.
8. Barnes SA, Young JW, Neill JC (2012). D receptor activation improves vigilance in rats as measured by the 5-choice continuous performance test. Psychopharmacology (Berl) 220: 129-141.
9. Baunez C, Robbins TW (1999). Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat. Neuroscience 92: 1343-1356.
10. Baviera M, Invernizzi RW, Carli M (2008). Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC. Psychopharmacology (Berl) 196: 269-280.
11. Boulougouris V, Castane A, Robbins TW (2009). Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior. Psychopharmacology (Berl) 202: 611-620.
12. Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D (1997). Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry 154: 805-811.
13. Cagniard B, Beeler JA, Britt JP, McGehee DS, Marinelli M, Zhuang X (2006). Dopamine scales performance in the absence of new learning. Neuron 51: 541-547.
14. Calcagno E, Carli M, Baviera M, Invernizzi RW (2009). Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade. J Neurochem 108: 521-532.
15. Calcagno E, Invernizzi RW (2010). Strain-dependent serotonin neuron feedback control: role of serotonin 2C receptors. J Neurochem 114: 1701-1710.
16. Carli M, Baviera M, Invernizzi RW, Balducci C (2006). Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology 31: 757-767.
17. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983). Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9: 361-380.
18. Carli M, Samanin R (1992). Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task. Psychopharmacology (Berl) 106: 228-234.
19. Ceglia I, Carli M, Baviera M, Renoldi G, Calcagno E, Invernizzi RW (2004). The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC. J Neurochem 91: 189-199.
20. Cepeda C, Buchwald NA, Levine MS (1993). Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci USA 90: 9576-9580.
21. Cepeda C, Colwell CS, Itri JN, Chandler SH, Levine MS (1998). Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. J Neurophysiol 79: 82-94.
22. Cepeda C, Hurst RS, Altemus KL, Flores-Hernandez J, Calvert CR, Jokel ES et al (2001). Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol 85: 659-670.
23. Chapman MA, See RE (1996). Differential effects of unique profile antipsychotic drugs on extracellular amino acids in the ventral pallidum and globus pallidus of rats. J Pharmacol Exp Ther 277: 1586-1594.
24. Chase TN, Oh JD (2000). Striatal dopamine-and glutamatemediated dysregulation in experimental parkinsonism. Trends Neurosci 23(10 Suppl): S86-91.
25. Christakou A, Robbins TW, Everitt BJ (2001). Functional disconnection of a prefrontal cortical-dorsal striatal system disrupts choice reaction time performance: implications for attentional function. Behav Neurosci 115: 812-825.
26. Chudasama Y, Baunez C, Robbins TW (2003). Functional disconnection of the medial prefrontal cortex and subthalamic nucleus in attentional performance: evidence for corticosubthalamic interaction. J Neurosci 23: 5477-5485.
27. Chudasama Y, Muir JL (2001). Visual attention in the rat: a role for the prelimbic cortex and thalamic nuclei? Behav Neurosci 115: 417-428.
28. Clarke HF, Robbins TW, Roberts AC (2008). Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci 28: 10972-10982.
29. Cole BJ, Robbins TW (1987). Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology (Berl) 91: 458-466.
30. Cole BJ, Robbins TW (1989). Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 33: 165-179.
31. Corbetta M, Miezin FM, Dobmeyer S, Shulman GL, Petersen SE (1991). Selective and divided attention during visual discriminations of shape, color, and speed: functional anatomy by positron emission tomography. J Neurosci 11: 2383-2402.
32. Dalley JW, McGaughy J, O'Connell MT, Cardinal RN, Levita L, Robbins TW (2001). Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task. J Neurosci 21: 4908-4914.
33. Dalley JW, Theobald DE, Eagle DM, Passetti F, Robbins TW (2002). Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 26: 716-728.
34. DeBiasi S, Minelli A, Melone M, Conti F (1996). Presynaptic NMDA receptors in the neocortex are both auto-and heteroreceptors. Neuroreport 7: 2773-2776.
35. Di Chiara G, Morelli M, Consolo S (1994). Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci 17: 228-233.
36. Divac I, Rosvold HE, Szwarcbart MK (1967). Behavioral effects of selective ablation of the caudate nucleus. J Comp Physiol Psychol 63: 184-190.
37. Donzanti BA, Yamamoto BK (1988). A rapid and simple HPLC microassay for biogenic amines in discrete brain regions. Pharmacol Biochem Behav 30: 795-799.
38. Flores-Hernandez J, Cepeda C, Hernandez-Echeagaray E, Calvert CR, Jokel ES, Fienberg AA et al (2002). Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32. J Neurophysiol 88: 3010-3020.
39. Flores-Hernandez J, Hernandez S, Snyder GL, Yan Z, Fienberg AA, Moss SJ et al (2000). D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade. J Neurophysiol 83: 2996-3004.
40. Fuster JM (1989). The Prefrontal Cortex. Second edition edn, Raven Press: New York.
41. Goto Y, Grace AA (2005). Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci 8: 805-812.
42. Gozzi A, Large CH, Schwarz A, Bertani S, Crestan V, Bifone A (2008). Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine. Neuropsychopharmacology 33: 1690-1703.
43. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW (2000). Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20: 1208-1215.
44. Graybiel AM (1998). The basal ganglia and chunking of action repertoires. Neurobiol Learn Mem 70: 119-136.
45. Groman SM, Lee B, London ED, Mandelkern MA, James AS, Feiler K et al (2011). Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. J Neurosci 31: 7291-7299.
46. Haluk DM, Floresco SB (2009). Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neuropsychopharmacology 34: 2041-2052.
47. Hernandez-Lopez S, Tkatch T, Perez-Garci E, Galarraga E, Bargas J, Hamm H et al (2000). D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2\+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin- signaling cascade. J Neurosci 20: 8987-8995.
48. Hersch SM, Ciliax BJ, Gutekunst CA, Rees HD, Heilman CJ, Yung KK et al (1995). Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15(7 Pt 2): 5222-5237.
49. Higgins GA, Enderlin M, Haman M, Fletcher PJ (2003). The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism. Psychopharmacology (Berl) 170: 309-319.
50. Hikosaka O, Miyashita K, Miyachi S, Sakai K, Lu X (1998). Differential roles of the frontal cortex, basal ganglia, and cerebellum in visuomotor sequence learning. Neurobiol Learn Mem 70: 137-149.
51. Homayoun H, Moghaddam B (2007). NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27: 11496-11500.
52. Invernizzi R, Pozzi L, Vallebuona F, Bonini I, Sacchetti G, Samanin R (1992). Effect of amineptine on regional extracellular concentrations of dopamine and noradrenaline in the rat brain. J Pharmacol Exp Ther 262: 769-774.
53. Jackson ME, Homayoun H, Moghaddam B (2004). NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci USA 101: 8467-8472.
54. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308.
55. Jin X, Costa RM (2010). Start/stop signals emerge in nigrostriatal circuits during sequence learning. Nature 466: 457-462.
56. Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V et al (2006). Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49: 603-615.
57. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
58. Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR et al (2009). Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci 29: 14734-14740.
59. Levine MS, Altemus KL, Cepeda C, Cromwell HC, Crawford C, Ariano MA et al (1996). Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1Adeficient mutant mice. J Neurosci 16: 5870-5882.
60. Lustig C, Kozak R, Sarter M, Young JW, Robbins TW (2012). CNTRICS final animal model task selection: control of attention. Neurosci Biobehav Rev; e-pub ahead of print 5 June 2012.
61. Matsumoto M, Kanno M, Togashi H, Ueno K, Otani H, Mano Y et al (2003). Involvement of GABAA receptors in the regulation of the prefrontal cortex on dopamine release in the rat dorsolateral striatum. Eur J Pharmacol 482: 177-184.
62. Mirjana C, Baviera M, Invernizzi RW, Balducci C (2004). The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex. Neuropsychopharmacology 29: 1637-1647.
63. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998). Dopamine receptors: from structure to function. Physiol Rev 78: 189-225.
64. Moghaddam B, Adams B, Verma A, Daly D (1997). Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927.
65. Moghaddam B, Adams BW (1998). Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281: 1349-1352.
66. Morari M, O'Connor WT, Ungerstedt U, Fuxe K (1994). Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-Daspartic acid. Eur J Pharmacol 256: 23-30.
67. Morari M, O'Connor WT, Ungerstedt U, Bianchi C, Fuxe K (1996). Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat-II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function. Neuroscience 72: 89-97.
68. Morari M, O'Connor WT, Ungerstedt U, Fuxe K (1993). N-methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat: an in vivo microdialysis study. J Neurochem 60: 1884-1893.
69. Onn SP, West AR, Grace AA (2000). Dopamine-mediated regulation of striatal neuronal and network interactions. Trends Neurosci 23(10 Suppl): S48-56.
70. Owen AM, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP et al (1992). Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115(Pt 6): 1727-1751.
71. Passetti F, Dalley JW, O'Connell MT, Everitt BJ, Robbins TW (2000). Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task. Eur J Neurosci 12: 3051-3058.
72. Passetti F, Levita L, Robbins TW (2003). Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions. Behav Brain Res 138: 59-69.
73. Pattij T, Janssen MC, Vanderschuren LJ, Schoffelmeer AN, van Gaalen MM (2007). Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control. Psychopharmacology (Berl) 191: 587-598.
74. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: Sidney.
75. Pennartz CM, Groenewegen HJ, Lopes da Silva FH (1994). The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog Neurobiol 42: 719-761.
76. Pezze MA, Dalley JW, Robbins TW (2007). Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task. Neuropsychopharmacology 32: 273-283.
77. Pezze MA, Dalley JW, Robbins TW (2009). Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D(2/3) receptor antagonist sulpiride. Psychopharmacology (Berl) 202: 307-313.
78. Ragozzino ME (2002). The effects of dopamine D(1) receptor blockade in the prelimbic-infralimbic areas on behavioral flexibility. Learn Mem 9: 18-28.
79. Redgrave P, Gurney K (2006). The short-latency dopamine signal: a role in discovering novel actions? Nat Rev Neurosci 7: 967-975.
80. Ridley RM, Clark BA, Durnford LJ, Baker HF (1993). Stimulusbound perseveration after frontal ablations in marmosets. Neuroscience 52: 595-604.
81. Robbins TW (1990). The case of frontostriatal dysfunction in schizophrenia. Schizophr Bull 16: 391-402.
82. Robbins TW (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163: 362-380.
83. Robbins TW (2005). Role of cortical and striatal dopamine in cognitive function. In: Dunnett SBBentivoglio MBjorklund A (eds) Dopamine Vol 21 (Elsevier B. V.: Amsterdam, pp 395-434.
84. Robertson GS, Vincent SR, Fibiger HC (1992). D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49: 285-296.
85. Robinson TE, Whishaw IQ (1988). Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res 450: 209-224.
86. Rogers RD, Baunez C, Everitt BJ, Robbins TW (2001). Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance. Behav Neurosci 115: 799-811.
87. Sawaguchi T, Goldman-Rakic PS (1991). D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251: 947-950.
88. Smith Y, Bevan MD, Shink E, Bolam JP (1998). Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86: 353-387.
89. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990). Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347: 146-151.
90. Taverna S, Canciani B, Pennartz CM (2005). Dopamine D1-receptors modulate lateral inhibition between principal cells of the nucleus accumbens. J Neurophysiol 93: 1816-1819.
91. Ungerstedt U (1971). Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367: 69-93.
92. van Schouwenburg MR, den Ouden HE, Cools R (2010). The human basal ganglia modulate frontal-posterior connectivity during attention shifting. J Neurosci 30: 9910-9918.
93. Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J (1997). Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)-and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 7: 25-38.
94. Wang H, Pickel VM (2002). Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol 442: 392-404.
95. West AR, Grace AA (2002). Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. J Neurosci 22: 294-304.
96. Yonezawa Y, Kuroki T, Kawahara T, Tashiro N, Uchimura H (1998). Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine- induced dopamine release in the medial prefrontal cortex. Eur J Pharmacol 341: 45-56.
97. Young AM, Bradford HF (1993). N-methyl-D-aspartate releases gamma-aminobutyric acid from rat striatum in vivo: a microdialysis study using a novel preloading method. J Neurochem 60: 487-492.
98. Zahrt J, Taylor JR, Mathew RG, Arnsten AF (1997). Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17: 8528-8535.